Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05007483 · ClinicalTrials.gov registry record · NA
Efficacy of Diet on Quality of Life in Multiple Sclerosis
A NA study of Multiple Sclerosis (Relapsing Remitting), sponsored by Terry L. Wahls.
- Active
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT05007483: Active NA study of Multiple Sclerosis (Relapsing Remitting), sponsored by Terry L. Wahls.
NCT05007483 is a NA study of Multiple Sclerosis (Relapsing Remitting) that is active but no longer recruiting, run by Terry L. Wahls. The registered enrollment target is 162 participants, below the 557-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05007483, a NA study of Multiple Sclerosis (Relapsing Remitting), is active but no longer recruiting, sponsored by Terry L. Wahls.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of two dietary interventions (time restricted olive oil based (TROO) ketogenic and modified Paleolithic elimination) on MS QoL compared to usual care control (Dietary Guidelines for America), and the secondary objectives and the long-term effects on, motor function, low-contrast vision sensitivity, fatigue, mood, and disease activity assessed by brain imaging.
Primary Outcome
Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT BodyBio Balance Oil
- DIETARY_SUPPLEMENT Kirunal Fish Oil
- DIETARY_SUPPLEMENT BodyBio PC
- BEHAVIORAL Modified Paleolithic Elimination diet
- BEHAVIORAL Time Restricted Olive Oil Based (TROO) Ketogenic Diet
Study Locations (1)
Iowa
- Univeristy of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What the registry record for NCT05007483 still lists
NCT05007483 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 557-participant average among 29 other Multiple Sclerosis (Relapsing Remitting) trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Multiple Sclerosis (Relapsing Remitting) appearing as the primary indexed condition, and to 5 interventions - of which BodyBio Balance Oil is the first listed.
NCT05007483 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT05007483 about?
NCT05007483 is a clinical study titled "Efficacy of Diet on Quality of Life in Multiple Sclerosis". The overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of two dietary interve...
What is the current status of trial NCT05007483?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2022-02-10. Estimated completion is 2026-12-01.
What conditions does trial NCT05007483 study?
This clinical trial studies the following conditions: Multiple Sclerosis (Relapsing Remitting).
What interventions are being tested in trial NCT05007483?
The interventions under investigation include: BodyBio Balance Oil (DIETARY_SUPPLEMENT), Kirunal Fish Oil (DIETARY_SUPPLEMENT), BodyBio PC (DIETARY_SUPPLEMENT), Modified Paleolithic Elimination diet (BEHAVIORAL), Time Restricted Olive Oil Based (TROO) Ketogenic Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT05007483?
This trial is sponsored by Terry L. Wahls, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05007483 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis (Relapsing Remitting)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05007483's enrollment target sits among peer trials
162 10th of 29 higher than 20 of 29 other Multiple Sclerosis (Relapsing Remitting) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis (Relapsing Remitting) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
RECRUITING · NA
-
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
RECRUITING · NA
-
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
RECRUITING · NA
-
The Synergistic Effects of AIH and FES in Persons With MS
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI